Marshall Wace, LLP Chembio Diagnostics, Inc. Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	BUY	$2.88 - $5.64 $31,613 - $61,910	10,977 New	10,977 $33,000
Q1 2021 May 17, 2021	SELL	$3.4 - $7.97 $601,735 - $1.41 Million	-176,981 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.11 - $7.51 $727,391 - $1.33 Million	176,981 New	176,981 $841,000
Q1 2019 May 14, 2019	SELL	$5.32 - $7.18 $80,220 - $108,267	-15,079 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.95 - $10.5 $74,641 - $158,329	15,079 New	15,079 $85,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.